Fluciclovine F 18

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameFluciclovine F 18
Drug Alias NameFluciclovine (18F)[18F]FluciclovineFluciclovine F-18FluciclovineAxumin +[12] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall moleculesRadiation-emitting products > Nuclides > Fluorine > 18F +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsRejection of pancreatic transplantationBone metastasesBrain metastases +[22] 
Global Approved IndicationsDiagnostic agentsProstatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/05/27
Country/TerritoryUnited StatesUnited KingdomEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBlue Earth Diagnostics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBlue Earth DiagnosticsUtah State UniversityNihon Medi-Physics Co Ltd +[11] 
Inactive CompaniesHALO Precision DiagnosticsGe HealthcareLoma Linda University +[5] 
Active IndicationsRejection of pancreatic transplantationBone metastasesBrain metastases +[19] 
Inactive IndicationsLung NeoplasmsHead and Neck NeoplasmsNeoplasms

Other Information

ATC CodeV09IX12
Related LinksWikipediaDrugBankKEGG